Alambic Investment Management, L.P. - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2018$382,000
-23.3%
163,200
+9.7%
0.10%
-10.3%
Q3 2016$498,000
+12.9%
148,800
+6.1%
0.12%
+5.4%
Q2 2016$441,000
+44.6%
140,300
+53.2%
0.11%
+12.1%
Q1 2016$305,000–91,600–0.10%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders